1. Home
  2. KPTI vs PFD Comparison

KPTI vs PFD Comparison

Compare KPTI & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.54

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Preferred and Income Fund Incorporated

PFD

Flaherty & Crumrine Preferred and Income Fund Incorporated

HOLD

Current Price

$11.55

Market Cap

152.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
PFD
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
152.5M
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
KPTI
PFD
Price
$8.54
$11.55
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.3M
19.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$22.36
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.65
$10.65
52 Week High
$10.99
$12.16

Technical Indicators

Market Signals
Indicator
KPTI
PFD
Relative Strength Index (RSI) 62.55 59.15
Support Level $5.84 $11.40
Resistance Level $9.00 $11.99
Average True Range (ATR) 0.61 0.12
MACD 0.34 0.06
Stochastic Oscillator 90.96 93.56

Price Performance

Historical Comparison
KPTI
PFD

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated

Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: